BPA Call HHSF223201510001B-75F40119F19006

Award Date 7/8/19
Potential Completion Date 8/28/23
Potential Value $666K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price BPA Call contract awarded by the Department of Health and Human Services Food and Drug Administration to Westat, Inc., a professional services firm, to conduct a "Healthcare Professional Survey of Prescription Drug Promotion II". The contract has a potential value of $642,813.00 and a completion date of December 16, 2020. It was awarded on May 16, 2017 under the Advertising & Integrated Marketing Solutions (AIMS) GSA Schedule and is classified under the...
This is a firm fixed-price BPA call awarded by the Food and Drug Administration (FDA) to Westat, Inc., a professional services firm headquartered in Rockville, Maryland. The contract is for $595,931.00 and has an ultimate completion date of August 14, 2028. It was awarded on July 25, 2024 under the Advertising & Integrated Marketing Solutions (AIMS) schedule through GSA. The contract is for "Adverse Event Rates in Direct-to-Consumer Prescription Drug Promotion" and does not have...
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price BPA Call contract to Westat, Inc., a for-profit professional services provider, to perform "Quick Turnaround Testing of Communication Effectiveness." The $260,330.00 task order was not set aside and is part of the Advertising & Integrated Marketing Solutions (AIMS) schedule under the General Services Administration. Westat has a history of providing research, technical assistance,...
This is a $699,513 firm fixed-price Blanket Purchase Agreement (BPA) call award made by the Food and Drug Administration (FDA) to Westat, Inc., a prominent professional services firm based in Rockville, Maryland. The contract is for services related to "Limited English Proficiency and Consumer Processing of Direct-to-Consumer Prescription Drug Ad Elements." The award is associated with the FDA's Advertising & Integrated Marketing Solutions (AIMS) Multiple Award Schedule contract...
This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Westat, Inc., a professional services firm based in Rockville, Maryland. The contract, valued at $169,624.00, is for a project titled "UNDERSTANDING THE USE OF PRESCRIBING INFORMATION IN THE HEALTH CARE SYSTEM" and is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract called "CDER Priority Analysis". The contract has no set-aside designation. Westat...
The Department of Health and Human Services Food and Drug Administration awarded Westat, Inc. a $154,730 firm fixed price blanket purchase agreement call under its Advertising & Integrated Marketing Solutions multiple award schedule contract. The purpose of this award is to provide quick turnaround social science research services to support FDA's prescription drug promotion in electronic health records initiative through conducting healthcare provider interviews. As the prime...
This contract was awarded by the Department of Health and Human Services Food and Drug Administration to Westat, Inc., a for-profit professional services firm, to provide "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES." The contract has a firm fixed price of $299,709.00 and a completion date of August 8, 2022. It was awarded on August 30, 2019 and utilizes the Advertising & Integrated Marketing Solutions (AIMS) GSA Schedule. Westat has experience as a prime and subcontractor...
This is a firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Westat, Inc., a professional services firm in Rockville, Maryland. The contract, with a ceiling value of $582,436.00, is for the "Endorsement III: Promotion of Prescription Drugs in Native Advertising" and is issued under the Advertising & Integrated Marketing Solutions (AIMS) Multiple Award Schedule (MAS) contract vehicle managed by the General Services Administration (GSA). The contract has...
This is a call order against Westat, Inc.'s "Quick Turnaround Social Science Research Services" blanket purchase agreement (BPA) with the Department of Health and Human Services (HHS) Food and Drug Administration (FDA). The $102,190.00 firm fixed price award has a completion date of June 13, 2023. Westat, a for-profit professional services firm, provides a range of research, technical assistance, and program support services to government agencies through prime and subcontractor roles....
This federal contract award is for a Blanket Purchase Agreement (BPA) issued by the Food and Drug Administration (FDA) for "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES" under the Advertising & Integrated Marketing Solutions (AIMS) GSA Schedule. The BPA was awarded to Westat, Inc., a prominent professional services firm that provides a wide range of research, technical assistance, and program support services to various federal agencies. The contract has a ceiling value of...

This is a firm-fixed-price BPA call contract awarded by the Department of Health and Human Services Food and Drug Administration to Westat, Inc., a for-profit professional services provider. The $665,677 contract is for "Communication of Contrary Data About Prescription Drugs", which falls under the QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES program. The contract is not set aside. Westat has a history of providing research, technical assistance, and program support services to various federal agencies through prime and subcontracts, as well as federal grants. The contract will likely involve activities such as survey research, data collection and analysis, and report production to inform policy on prescription drug communication.

Generated 3/22/24, 6:05 PM